UA103309C2 - Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen - Google Patents
Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofenInfo
- Publication number
- UA103309C2 UA103309C2 UAA201007842A UAA201007842A UA103309C2 UA 103309 C2 UA103309 C2 UA 103309C2 UA A201007842 A UAA201007842 A UA A201007842A UA A201007842 A UAA201007842 A UA A201007842A UA 103309 C2 UA103309 C2 UA 103309C2
- Authority
- UA
- Ukraine
- Prior art keywords
- sulfate salt
- ibuprofen
- pharmaceutical composition
- oral administration
- chondroitin sulfate
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to the field of medicine and, more particularly, to drugs for internal use to treat a pain syndrome during a pain exacerbation phase in primary osteoarthrosis and secondary osteoarthrosis and other degenerative dystrophic diseases of extremity joints and intervertebral disks. The pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen as a nonsteroidal anti-inflammatory drug, and auxiliary substances wherein the ingredients are comprised in the following ingredient ratio (% w/w): Chondroitin sulfate salt 20 to 30 Glucosamine sulfate salt 30 to 36 Ibuprofen 10 to 15 and auxiliary substances Q, S. The present invention provides a pharmaceutical composition which ensures a chondroprotective, anti-inflammatory, and analgetic effect, an effective treatment of degenerative dystrophic diseases of extremity joints and intervertebral disks, a convenience of using the medicine, decrease in side effect risks, and the provision of an alternative medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201007842A UA103309C2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2007012960 | 2007-11-23 | ||
| UAA201007842A UA103309C2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen |
| PCT/EP2008/009897 WO2009065604A2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA103309C2 true UA103309C2 (en) | 2013-10-10 |
Family
ID=52283150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201007842A UA103309C2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA103309C2 (en) |
-
2008
- 2008-11-21 UA UAA201007842A patent/UA103309C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2470016C2 (en) | Bipirazole derivative | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| SI2529622T1 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2008027350A3 (en) | Acetaminophen pharmaceutical compositions | |
| HRP20230272T1 (en) | Methods of treatment for cystic fibrosis | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| IL196425A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
| Lee et al. | Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial | |
| WO2005035485A3 (en) | Analgesic compounds, their synthesis and pharmaceutical compositions containing them | |
| US20190374491A1 (en) | Topical preparation for pain relief | |
| WO2007064448A3 (en) | Cancer treatment using fts and 2-deoxyglucose | |
| BR112013010829B8 (en) | Intravenous pharmaceutical composition to provide relief from pain and/or inflammation | |
| AU2009304002B9 (en) | A medicinal product and treatment | |
| WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
| WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
| JP2016505050A5 (en) | ||
| UA93365C2 (en) | Injectable preparations of diclofenic and its pharmaceutically acceptable salts, and processes for the preparation thereof | |
| CA2476939A1 (en) | Pharmaceutical combinations of cox-2 inhibitors and opiates | |
| Rose et al. | Comparison of lornoxicam and rofecoxib in patients with activated osteoarthritis (COLOR Study) | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| WO2009065604A3 (en) | Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene | |
| UA103309C2 (en) | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen | |
| ZA202101688B (en) | Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain | |
| WO2020036478A3 (en) | Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses |